PL
Paul F. Lizzul (Chief Medical Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in AnaptysBio, Inc. (ANAB). The largest single filing was $183K of ANAB (4,219 sh × $43.26, as filed), executed Jan 5. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$447K
shares × price, as filed
Last traded
Jan 8
Filed Jan 9
Median ADV $28.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $447K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
ANABRecent filings
ANABSALE
AnaptysBio, Inc.
View filing →
$163K3,650 sh × $44.71
Exec Jan 8
Filed Jan 9 · 5:30 PM ET ANABSALE AnaptysBio, Inc. View filing → $101K
2,235 sh × $45.11
Exec Jan 7
Filed Jan 8 · 5:30 PM ET ANABSALE AnaptysBio, Inc. View filing → $183K
4,219 sh × $43.26
Exec Jan 5
Filed Jan 6 · 5:30 PM ET